ERBB2 and breast carcinoma: Many of these pathways, such as Notch, Wnt, NF-kB, Sonic Hedgehog (SHH), ER, PI3K/Akt/mTOR, and HER2, are emerging as promising therapeutic targets in breast cancer [16].